16 July 2014

NICE, Level 1, City Tower, Piccadilly Plaza, Manchester

The meeting will start promptly at 10:30 and is anticipated to finish by 16:00

Venue: NICE, Level 1, City Tower, Piccadilly Plaza, Manchester, M1 4BT

Please note that is subject to change prior to the meeting.

Final Agenda

1. Welcome and introduction to format of meeting

2. Apologies

3. Any other business

4. Assessment of Fluorouracil plasma monitoring: the My5-FU assay for guiding dose adjustment in patients receiving fluorouracil chemotherapy by continuous infusion

4.1. Declarations of interest - Part 1 only (open session)

4.2. Introduction by the Chair, Professor Adrian Newland - Part 1 only (open session)

4.3. Presentation by the Lead team, Steve Edwards, Steve Thomas, Simon Davidson/ Topic lead Rebecca Albrow of themed consultation comments- Part 1 and Part 2 (open and closed session)

4.4. Agreement on the content of the Diagnostics Consultation Document (DCD) - Part 2 only (closed session)

PDF version of draft agenda 

Date, time and venue of next meeting.

Next Diagnostics Advisory Committee Meeting: Tuesday 19 August 2014, 10.30 - 16.00, 
Venue: Level 1a, City Tower, Piccadilly Plaza, Manchester, M1 4BT

Please note all timings are approximate.

 

Registration period: 24 June 2014 to 02 July 2014
Registration is closed.